These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23824468)

  • 1. Monitoring in clinical trials: benefit or bias?
    Nardini C
    Theor Med Bioeth; 2013 Aug; 34(4):259-74. PubMed ID: 23824468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Panel discussion 2.
    Lan G; Lindborg S; Neaton J
    Clin Trials; 2012 Dec; 9(6):736-40. PubMed ID: 23250944
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trials with sequential analysis that were early-stopped: How to interpret them?
    Garegnani LI; Arancibia M; Madrid E; Franco JVA
    Medwave; 2020 Jun; 20(5):e7930. PubMed ID: 32603319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controversy trails adaptive clinical trials.
    Goozner M
    J Natl Cancer Inst; 2012 Sep; 104(18):1347-8. PubMed ID: 22984199
    [No Abstract]   [Full Text] [Related]  

  • 5. Statistical decisions and the interim analyses of clinical trials.
    Stanev R
    Theor Med Bioeth; 2011 Feb; 32(1):61-74. PubMed ID: 21222041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation of the impact of futility analysis in publicly funded trials.
    Sully BG; Julious SA; Nicholl J
    Trials; 2014 Feb; 15():61. PubMed ID: 24533447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What can we do about exploratory analyses in clinical trials?
    Moyé L
    Contemp Clin Trials; 2015 Nov; 45(Pt B):302-310. PubMed ID: 26390962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. You may have worked on more adaptive designs than you think.
    Coffey CS
    Stroke; 2015 Feb; 46(2):e26-8. PubMed ID: 25572412
    [No Abstract]   [Full Text] [Related]  

  • 9. Reporting clinical trials: full access to all the data.
    Rosenberg RN; Aminoff M; Boller F; Soelberg P; Griggs RC; Hachinski V; Hallett M; Johnson RT; Kennard C; Lang AE; Lees AJ; Lisak R; Newsom-Davis J; Pedley TA; Selzer ME; Zochodne D
    Stroke; 2001 Dec; 32(12):2734. PubMed ID: 11739964
    [No Abstract]   [Full Text] [Related]  

  • 10. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies.
    Briggs AH; O'Brien BJ; Blackhouse G
    Annu Rev Public Health; 2002; 23():377-401. PubMed ID: 11910068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research.
    Wells KB
    Am J Psychiatry; 1999 Jan; 156(1):5-10. PubMed ID: 9892291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome.
    Choodari-Oskooei B; Parmar MK; Royston P; Bowden J
    Trials; 2013 Jan; 14():23. PubMed ID: 23343147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of clinical trials: A panel discussion.
    D'Agostino R; DeMets D; Friedewald W; Goodman S; Witte J; Geller NL
    Stat Med; 2012 Nov; 31(25):3068-72. PubMed ID: 22806631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investment appraisal approach to clinical trial design.
    Backhouse ME
    Health Econ; 1998 Nov; 7(7):605-19. PubMed ID: 9845254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using covariates to reduce uncertainty in the economic evaluation of clinical trial data.
    Vázquez-Polo FJ; Negrín Hernández MA; López-Valcárcel BG
    Health Econ; 2005 Jun; 14(6):545-57. PubMed ID: 15497202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive design of confirmatory trials: Advances and challenges.
    Lai TL; Lavori PW; Tsang KW
    Contemp Clin Trials; 2015 Nov; 45(Pt A):93-102. PubMed ID: 26079372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of genuine prior information in cost-effectiveness analysis of clinical trial data.
    Stevens JW; O'Hagan A
    Int J Technol Assess Health Care; 2002; 18(4):782-90. PubMed ID: 12602079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive design in clinical research: issues, opportunities, and recommendations.
    Chang M; Chow SC; Pong A
    J Biopharm Stat; 2006 May; 16(3):299-309; discussion 311-2. PubMed ID: 16724486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying over-estimation in early stopped clinical trials and the "freezing effect" on subsequent research.
    Wang H; Rosner GL; Goodman SN
    Clin Trials; 2016 Dec; 13(6):621-631. PubMed ID: 27271682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICON4/AGO-OVAR-2.2: questions about trial design, cost-effectiveness, and clinical benefit.
    Wheatley K; Gray R
    Lancet; 2003 Oct; 362(9392):1333; author reply 1334. PubMed ID: 14575997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.